(Q51322420)
Statements
Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes. (English)
1 reference
C-J Li
1 reference
Q Yu
1 reference
P Yu
1 reference
Q-M Zhang
1 reference
M Ding
1 reference
X-J Liu
1 reference
D-M Yu
1 reference
16 May 2014
1 reference
122
1 reference
8
1 reference
469-476
1 reference